Related Experiment Video
Updated: Aug 16, 2026

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
[Bacterial biofilms and infection]
I Lasa1, J L Del Pozo, J R Penadés
1Laboratorio de Biofilms Microbianos, Istituto de Agrobiotecnología, Universidad Pública de Navarra, Mutilva Baja, 31192, Spain. ilasa@unavarra.es
Abstract:
In developed countries we tend to think of heart disease and the numerous forms of cancer as the main causes of mortality, but on a global scale infectious diseases come close, or may even be ahead: 14.9 million deaths in 2002 compared to cardiovascular diseases (16.9 million deaths) and cancer (7.1 million deaths) (WHO report 2004). The infectious agents responsible for human mortality have evolved as medical techniques and hygienic measures have changed. Modern-day acute infectious diseases caused by specialized bacterial pathogens such as diphtheria, tetanus, cholera, plague, which represented the main causes of death at the beginning of XX century, have been effectively controlled with antibiotics and vaccines. In their place, more than half of the infectious diseases that affect mildly immunocompromised patients involve bacterial species that are commensal with the human body; these can produce chronic infections, are resistant to antimicrobial agents and there is no effective vaccine against them. Examples of these infections are the otitis media, native valve endocarditis, chronic urinary infections, bacterial prostatitis, osteomyelitis and all the infections related to medical devices. Direct analysis of the surface of medical devices or of tissues that have been foci of chronic infections shows the presence of large numbers of bacteria surrounded by an exopolysaccharide matrix, which has been named the "biofilm". Inside the biofilm, bacteria grow protected from the action of the antibodies, phagocytic cells and antimicrobial treatments. In this article, we describe the role of bacterial biofilms in human persistent infections.
Insights
Bacterial biofilms, a protective matrix of bacteria, are increasingly responsible for persistent human infections. These resilient communities evade immune responses and antimicrobial treatments, posing a significant global health challenge.
Area of Science:
- Microbiology
- Infectious Diseases
- Public Health
Background:
- Infectious diseases remain a major global cause of mortality, rivaling cardiovascular diseases and cancer.
- Historically acute bacterial infections are now controlled by antibiotics and vaccines.
- Commensal bacteria increasingly cause chronic, antimicrobial-resistant infections in immunocompromised individuals.
Purpose of the Study:
- To describe the role of bacterial biofilms in human persistent infections.
- To highlight the shift in infectious disease patterns towards chronic, biofilm-associated infections.
- To underscore the challenges posed by biofilms in treating recurrent and device-related infections.
Main Methods:
- Analysis of bacterial presence on medical devices.
- Examination of tissues from chronic infection sites.
- Review of scientific literature on bacterial biofilms and persistent infections.
Main Results:
- Bacteria in chronic infections and on medical devices are often encased in an exopolysaccharide matrix, termed a biofilm.
- Biofilms provide a protective environment for bacteria, shielding them from antibodies and phagocytic cells.
- Bacteria within biofilms exhibit increased resistance to antimicrobial agents.
Conclusions:
- Bacterial biofilms play a critical role in the pathogenesis of persistent human infections.
- The protective nature of biofilms contributes to treatment failures and recurrent infections.
- Understanding biofilm formation is crucial for developing new strategies against chronic infectious diseases.
Related Concept Videos
Biofilms
Bacterial Signaling
Colonisation of Pathogens
Gene Regulation in Microbial Communities: Quorum Sensing
Determinants of Bacterial Pathogenicity and Virulence
Bacterial Meningitis
